Bipolar disorder Flashcards
Lithium dosing
Narrow therapeutic index
Acute treatment: 0.9-1.2 mEq/L
Maintenance: 0.6-0.9 mEq/L
Toxicity: 1.5- > 3.0 mEq/L
Lithium side effects
Fine hand tremor
Hypothyroidism
Polyuria
Dry mouth
ECG changes
Diabetes
Weight gain
Polydipsia
Acne
Lithium toxicities
Coarse hand tremor
GI
Ataxia
Altered mental status
Lethargy
Confusion
Agitation
Seizure
Lithium Teratogenic
Cardiac structure abnormality (Ebstein’s anomaly)
Avoid in 1st trimester
Lithium monitoring
Scr,BUN
Urine specific gravity
Na, K, Ca
ECG (esp. > 40 yo)
TSH, T4
CBC
Parathyroid hormone
Weight
Pregnancy test
Lithium drug interactions
Increase levels with: ACE/ARB, Thiazides, NSAIDS
Decrease levels with: caffeine, osmotic diuretics, loop diuretics, NaHCO3, high Na
Valproate
inhibits Na and Ca channels
Increase GABA levels
Valproate dosages
ER is 10-15% less bioavailable than DR
1:1 conversion, expect lower serum concentration with the ER form usually not clinically significant
Valproic acid syrup (IR) and capsule sprinkle–> increase risk for GI ulcers
Serum levels 80-125 mcg/mL
Valproate side effects
GI symptoms
Hyperammonemia
Hepatotoxicity (LFT)
Thrombocytopenia
PCOS, weight gain, sedation
Contraindication with valproate
Pregnancy (neural tube defects and decrease IQ)
Baseline pregnancy test
Valproate drug interaction
LAMOTRIGINE
steven johnson syndrome
Carbamazepine
2nd/3rd line
associated with thrombocytopenia/hematologic effects
Oxcarbazepine
hyponatremia
Lamotrigine
1st line for depressive symptoms
not useful for acute treatment/manic episodes
retitrate if non-adherence for > 3-5 days
Topiramate
May cause weight loss
Heat intolerance/hypohidrosis
Metabolic acidosis and kidney stones
Possible teratogen–cardiac structural defects